NASH
Clinical trials for NASH explained in plain language.
Never miss a new study
Get alerted when new NASH trials appear
Sign up with your email to follow new studies for NASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common heart pill treat fatty liver?
Disease control Recruiting nowThis study tests whether a low dose of digoxin, a drug normally used for heart problems, can help people with a severe type of fatty liver disease called NASH (also known as MASH). About 144 adults with confirmed NASH and liver scarring will take digoxin or a placebo for a period…
Matched conditions: NASH
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 17, 2026 02:57 UTC
-
New pill aims to shrink fatty liver in 12 weeks
Disease control Recruiting nowThis study tests a new tablet, CS060380, for non-alcoholic steatohepatitis (NASH), a serious liver condition. About 120 adults will take the drug or a placebo daily for 12 weeks. Researchers will measure changes in liver fat using MRI and track any side effects.
Matched conditions: NASH
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
Can genes predict liver cancer in fatty liver patients?
Knowledge-focused Recruiting nowThis study looks at how certain genes increase the risk of liver cancer (hepatocellular carcinoma) in people with nonalcoholic fatty liver disease (NAFLD). Researchers will follow 500 adults aged 45-75 with NAFLD to understand genetic factors and develop a risk score. The goal is…
Matched conditions: NASH
Phase: NA • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated May 17, 2026 02:55 UTC
-
Hormone link to fatty liver in young women under microscope
Knowledge-focused Recruiting nowThis study looks at how androgens (a type of sex hormone) might affect fatty liver disease in young women. Researchers will compare women with PCOS (who often have high androgen levels) to those without PCOS. The goal is to understand changes in liver fat and stiffness over time.…
Matched conditions: NASH
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
New NASH drug candidate BAR502 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study tests whether BAR502 is safe and tolerable in healthy adults. It involves 52 participants aged 18-55 who will receive either the drug or a placebo. The goal is to understand how the body processes BAR502 and identify any side effects before testing it in pe…
Matched conditions: NASH
Phase: PHASE1 • Sponsor: BAR Pharmaceuticals s.r.l. • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC